Outcomes of anticoagulant (AC) or antiplatelet (AP) use in patients (pts) with chronic lymphocytic leukemia (CLL) or indolent non-Hodgkin's lymphoma (iNHL) in idelalisib (IDELA) trials Meeting Abstract


Authors: Stilgenbauer, S.; Barrientos, J.; Ghia, P.; Pagel, J.; Salles, G. A.; Sharman, J. P.; Gurtovaya, O.; Kim, Y.; Philip, B.; Zelenetz, A. D.
Abstract Title: Outcomes of anticoagulant (AC) or antiplatelet (AP) use in patients (pts) with chronic lymphocytic leukemia (CLL) or indolent non-Hodgkin's lymphoma (iNHL) in idelalisib (IDELA) trials
Meeting Title: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie
Journal Title: Oncology Research and Treatment
Volume: 38
Issue: Suppl. 5
Meeting Dates: 2015 Oct 9-13
Meeting Location: Basel, Switzerland
ISSN: 2296-5270
Publisher: S. Karger AG  
Date Published: 2015-10-01
Start Page: 92
End Page: 93
Language: English
ACCESSION: WOS:000364268800215
PROVIDER: wos
PUBMED: 26461956
DOI: 10.1159/000439070
Notes: Meeting Abstract: V293 -- [Annual Meeting of the German, Austrian and Swiss Societies for Haematology and Medical Oncology] -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew D Zelenetz
    767 Zelenetz